Palliative and End-of-Life Care During Critical Cardiovascular Illness: A Scientific Statement From the American Heart Association

E Erin A. Bohula (Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston) M Michael J. Landzberg V Venu Menon (Cleveland Clinic Coordinating Center for Clinical Research (C5 Research), Cleveland Clinic, Cleveland) C Carlos L. Alviar G Gregory W. Barsness D Daniela R. Crousillat N Nelia Jain R Robert Page (University of Colorado Skaggs School of Pharmacy, Aurora, Colorado, United States) R Rachel Wells A Abdulla A. Damluji

Abstract

Cardiac intensive care units are witnessing a demographic shift, characterized by patients with increasingly complex or end-stage cardiovascular disease with a greater burden of concomitant comorbid noncardiovascular disease. Despite technical advances in care that may be offered, many critically ill cardiovascular patients will nevertheless experience significant morbidity and mortality during the acute decompensation, including physical and psychological suffering. Palliative care, with its specialized focus on alleviating suffering, aligns treatments with patient and caregiver values and improves overall care planning. Integrating palliative care into cardiovascular disease management extends the therapeutic approach beyond life-sustaining measures to encompass life-enhancing goals, addressing the physical, emotional, psychosocial, and spiritual needs of critically ill patients. This American Heart Association scientific statement aims to explore the definitions and conceptual framework of palliative care and to suggest strategies to integrate palliative care principles into the management of patients with critical cardiovascular illness.

Article Details

Journal Circulation
Volume / Issue Vol. 151, Issue 24
Published June 17, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (10)

E

Erin A. Bohula

Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston

M

Michael J. Landzberg

V

Venu Menon

Cleveland Clinic Coordinating Center for Clinical Research (C5 Research), Cleveland Clinic, Cleveland

C

Carlos L. Alviar

G

Gregory W. Barsness

D

Daniela R. Crousillat

N

Nelia Jain

R

Robert Page

University of Colorado Skaggs School of Pharmacy, Aurora, Colorado, United States

R

Rachel Wells

A

Abdulla A. Damluji